Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Chronic Heart Failure |
Free Subscription
2 Am Heart J |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Chronic Heart Failure is free of charge.
The Prognostic Significance of Single-Lead ST-Segment Resolution in ST-Segment
Elevation Myocardial Infarction Patients Treated with Primary PCI - A Substudy of
the Randomized TOTAL Trial.
Am Heart J. 2023 Dec 16:S0002-8703(23)00347-2. doi: 10.1016/j.ahj.2023.
PubMed
Abstract available
Empagliflozin to elderly and obese patients with increased risk of developing
heart failure: Study protocol for the Empire Prevent trial program.
Am Heart J. 2024 Feb 14:S0002-8703(24)00032-2. doi: 10.1016/j.ahj.2024.
PubMed
Abstract available
Hypertrophic Cardiomyopathy: A Brief Overview.
Am J Cardiol. 2024;212S:S1-S3.
PubMed
Abstract available
Medical Treatment Strategies for Hypertrophic Cardiomyopathy.
Am J Cardiol. 2024;212S:S33-S41.
PubMed
Abstract available
Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low
Disease-Related Mortality in 2023.
Am J Cardiol. 2024;212S:S77-S82.
PubMed
Abstract available
Racial Differences in Hospice Care Outcomes Among Patients with Advanced Heart
Failure: Systematic Review and Meta-analysis.
Am J Cardiol. 2024 Feb 19:S0002-9149(24)00096.
PubMed
Abstract available
Exposure-response associations between chronic exposure to fine particulate
matter and risks of hospital admission for major cardiovascular diseases:
population based cohort study.
BMJ. 2024;384:e076939.
PubMed
Abstract available
Conduction System Stimulation to Avoid Left Ventricle Dysfunction.
Circ Arrhythm Electrophysiol. 2024;17:e012473.
PubMed
Abstract available
Implications of Mitral Annular Calcification on Outcomes Following Mitral
Transcatheter Edge-to-Edge Repair.
Circ Cardiovasc Interv. 2024;17:e013424.
PubMed
Abstract available
Ethical Complexity of Medical Treatment Affordability and Clinical Trial
Diversity in Heart Failure.
Circ Cardiovasc Qual Outcomes. 2024;17:e010227.
PubMed
TAVI With ACURATE neo2 Valve in Aortic Regurgitation Due to Left Ventricular
Assist Device: A Custom-Made Option.
Circ Heart Fail. 2024 Jan 12:e010719. doi: 10.1161/CIRCHEARTFAILURE.123.010719.
PubMed
Ongoing Enigma of NT-proBNP in HFpEF: Insights From Proteomics.
Circ Heart Fail. 2024;17:e011428.
PubMed
Beyond Tiers: Examination of the French Heart Allocation System.
Circ Heart Fail. 2024;17:e011312.
PubMed
Enhancing the Prediction of Cardiac Allograft Vasculopathy Using Intravascular
Ultrasound and Machine Learning: A Proof of Concept.
Circ Heart Fail. 2024 Feb 5:e011306. doi: 10.1161/CIRCHEARTFAILURE.123.011306.
PubMed
Abstract available
Failing to Make the Grade: Conventional Cardiac Allograft Rejection Grading
Criteria Are Inadequate for Predicting Rejection Severity.
Circ Heart Fail. 2024;17:e010950.
PubMed
Abstract available
CHKB-DT: A Long Noncoding RNA Critical for Cardiovascular Health.
Circ Res. 2024;134:442-444.
PubMed
From Gut to Heart: Role of Indole-3-Propionic Acid in HFpEF.
Circ Res. 2024;134:390-392.
PubMed
In-hospital outcomes in unhoused patients with cardiogenic shock in the United
States: Insights from The National Inpatient Sample 2011-2019.
Clin Cardiol. 2024;47:e24235.
PubMed
Abstract available
Association between performance measures and clinical outcomes in patients with
heart failure in China: Results from the HERO study.
Clin Cardiol. 2024;47:e24233.
PubMed
Abstract available
Fully magnetically centrifugal left ventricular assist device and long-term
outcomes: the ELEVATE registry.
Eur Heart J. 2023 Nov 30:ehad658. doi: 10.1093.
PubMed
Abstract available
New opportunity for targeting systemic inflammation in patients with heart
failure through leucocyte immunomodulation.
Eur J Heart Fail. 2024 Feb 23. doi: 10.1002/ejhf.3177.
PubMed
Correction to 'Congestion in heart failure: a circulating biomarker-based
perspective. A review from the Biomarkers Working Group of the Heart Failure
Association, European Society of Cardiology'.
Eur J Heart Fail. 2024 Feb 20. doi: 10.1002/ejhf.3171.
PubMed
Reply to 'Vasodilators in congestive heart failure: The perfect weapon aiming
just off the target?'.
Eur J Heart Fail. 2024 Feb 20. doi: 10.1002/ejhf.3159.
PubMed
Use of natriuretic peptides and echocardiography for diagnosing heart failure.
Eur J Heart Fail. 2024 Feb 20. doi: 10.1002/ejhf.3165.
PubMed
Abstract available
Clinical implications of subclinical left ventricular dysfunction in heart
failure with preserved ejection fraction: The PARAGON-HF study.
Eur J Heart Fail. 2024 Feb 18. doi: 10.1002/ejhf.3167.
PubMed
Abstract available
Kidney involvement in transthyretin cardiac amyloidosis - Role of urinary albumin
to creatinine ratio and need for further evidence generation.
Eur J Heart Fail. 2024;26:74-76.
PubMed
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive
cardiomyopathy population.
Eur J Heart Fail. 2024;26:59-64.
PubMed
Abstract available
Growth differentiation factor-15 in sodium-glucose cotransporter 2 inhibition:
Mechanistic insights from the EMPEROR program.
Eur J Heart Fail. 2024;26:165-166.
PubMed
Sacubitril/valsartan: Where mechanism meets evidence-based medicine.
Eur J Heart Fail. 2024;26:127-129.
PubMed
Mineralocorticoid receptor antagonist indication and underuse in high-risk
post-myocardial infarction patients.
Eur J Heart Fail. 2024;26:140-141.
PubMed
The global landscape of peripartum cardiomyopathy: Morbidity, mortality, recovery
and inequity.
Eur J Heart Fail. 2024;26:43-45.
PubMed
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and
prognostic importance.
Eur J Heart Fail. 2024;26:65-73.
PubMed
Abstract available
Coronary artery disease and dilated cardiomyopathy: Where parallel universes
merge.
Eur J Heart Fail. 2024;26:56-58.
PubMed
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction
patients stratified according to use of mineralocorticoid receptor antagonists:
Insight from the PARADISE MI trial.
Eur J Heart Fail. 2024;26:130-139.
PubMed
Abstract available
Clinical characteristics and prognosis of patients with isolated cardiac
sarcoidosis: Insights from the ILLUMINATE-CS study.
Eur J Heart Fail. 2024;26:77-86.
PubMed
Abstract available
Outcomes at one year in women with peripartum cardiomyopathy: Findings from the
ESC EORP PPCM Registry.
Eur J Heart Fail. 2024;26:34-42.
PubMed
Abstract available
Assessing the association between genetic and phenotypic features of dilated
cardiomyopathy and outcome in patients with coronary artery disease.
Eur J Heart Fail. 2024;26:46-55.
PubMed
Abstract available
Association of right atrial strain and long-term outcome in severe secondary
tricuspid regurgitation.
Heart. 2023 Oct 30:heartjnl-2023-323084. doi: 10.1136/heartjnl-2023-323084.
PubMed
Abstract available
Augmenting reality in echocardiography.
Heart. 2023 Nov 8:heartjnl-2023-323443. doi: 10.1136/heartjnl-2023-323443.
PubMed
Sympathetic Neural Control at Rest and During the Cold Pressor Test in Patients
With Heart Failure With Preserved Ejection Fraction.
Hypertension. 2024 Feb 22. doi: 10.1161/HYPERTENSIONAHA.123.21918.
PubMed
Abstract available
Safety of sacubitril/valsartan among older adults. Where real world data meet
clinical trials results.
Int J Cardiol. 2024;400:131706.
PubMed
Comparative analysis of different risk prediction tools after mitral
Transcatheter edge-to-edge repair.
Int J Cardiol. 2024;400:131768.
PubMed
Abstract available
Mitral valve gradient changes associate with outcomes of patients undergoing
transcatheter edge-to-edge repair.
Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
PubMed
Abstract available
Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the
Veneto Region, Italy.
Int J Cardiol. 2024;400:131804.
PubMed
Abstract available
Left ventricular assist device in the presence of subcutaneous implantable
cardioverter defibrillator: Data from a multicenter experience.
Int J Cardiol. 2024 Jan 23:131807. doi: 10.1016/j.ijcard.2024.131807.
PubMed
Abstract available
Relationship between resting heart rate and long-term outcomes in stabilized
patients with myocardial infarction: A prospective community-based cohort study.
Int J Cardiol. 2024 Jan 24:131811. doi: 10.1016/j.ijcard.2024.131811.
PubMed
Abstract available
Expert recommendations for the management of iron deficiency in patients with
heart failure in Asia.
Int J Cardiol. 2024 Feb 19:131890. doi: 10.1016/j.ijcard.2024.131890.
PubMed
Abstract available
Exercise mean PAP to CO relationship: An insightful endpoint for testing
therapeutic interventions in heart failure.
Int J Cardiol. 2024 Feb 20:131899. doi: 10.1016/j.ijcard.2024.131899.
PubMed
Mitochondrial dysfunction due to miR-210/Drd5/ROS axis is a potential mechanism
of heart failure.
Int J Cardiol. 2024 Feb 20:131897. doi: 10.1016/j.ijcard.2024.131897.
PubMed
Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer.
J Am Coll Cardiol. 2024;83:827-838.
PubMed
Abstract available
Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic
Cardiomyopathies.
J Am Coll Cardiol. 2024;83:797-807.
PubMed
Abstract available
Contemporary Care and Outcomes of Critically-ill Children With Clinically
Diagnosed Myocarditis.
J Card Fail. 2024;30:350-358.
PubMed
Abstract available
Improving Outcomes for Critically Ill Children With Myocarditis.
J Card Fail. 2024;30:359-361.
PubMed
Heart Transplant Human Leukocyte Antigen Matching in the Modern Era.
J Card Fail. 2024;30:362-372.
PubMed
Abstract available
Harnessing Precision Medicine: HLA or Eplet Matching in Heart Transplantation.
J Card Fail. 2024;30:373-375.
PubMed
Impact of Structured Resistance Training on Locomotor Muscle Composition in
Patients with HFpEF.
J Card Fail. 2024;30:410-414.
PubMed
Nebulized Milrinone: Choosing Next Steps Wisely.
J Card Fail. 2024;30:337-339.
PubMed
Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based
Strategies Are Needed.
J Card Fail. 2024;30:418-420.
PubMed
The Heart as a Reminder for Oneness.
J Card Fail. 2024;30:317-318.
PubMed
A Board of Our Own: The New American Board for Cardiovascular Medicine.
J Card Fail. 2024;30:421.
PubMed
Low levels of selenoprotein P associate with cognitive impairment in patients
hospitalized for heart failure.
J Card Fail. 2024 Feb 14:S1071-9164(24)00039.
PubMed
Abstract available
Patient and Provider Factors Associated With Initiating Sodium-Glucose
Cotransporter-2 Inhibitors (SGTL2i) Following FDA Approval for Heart Failure with
Preserved and Mildly Reduced Ejection Fraction.
J Card Fail. 2024 Feb 15:S1071-9164(24)00035.
PubMed
Impella - Current issues and future expectations for the percutaneous, microaxial
flow left ventricular assist device.
J Cardiol. 2024;83:228-235.
PubMed
Abstract available
Role of splanchnic circulation in the pathogenesis of heart failure:
State-of-the-art review.
J Cardiol. 2024 Feb 16:S0914-5087(24)00022-4. doi: 10.1016/j.jjcc.2024.
PubMed
Abstract available
Neutrophils are indispensable for adverse cardiac remodeling in heart failure.
J Mol Cell Cardiol. 2024;189:1-11.
PubMed
Abstract available
Heart failure with preserved ejection fraction: everything the clinician needs to
know.
Lancet. 2024 Feb 14:S0140-6736(23)02756-3. doi: 10.1016/S0140-6736(23)02756.
PubMed
Abstract available
Health outcomes after myocardial infarction: A population study of 56 million
people in England.
PLoS Med. 2024;21:e1004343.
PubMed
Abstract available
Thank you for your interest in scientific medicine.